Zidovudine News and Research

RSS
Zidovudine was approved by the FDA on March 19, 1987, with other antiretroviral agents for the treatment of HIV infection in adults and in children 3 months of age or older. This medicine is also approved for use in HIV infected women to prevent the virus from being passed to their babies during pregnancy and delivery. It is then given to these babies for the first 6 weeks of life. Although the FDA does not approve this practice, zidovudine may be used to prevent workers from getting HIV infection after they accidentally come into contact with the virus on the job. This medicine does not cure or prevent HIV infection or AIDS and does not reduce the risk of passing the virus to other people.
FDA reinforces use of Sustiva in first-line HIV combination therapy

FDA reinforces use of Sustiva in first-line HIV combination therapy

26 Aug 2004
New guidelines for antiretroviral drugs to prevent the transmission of HIV from mothers to their children

New guidelines for antiretroviral drugs to prevent the transmission of HIV from mothers to their children

15 Jul 2004
AIDS Healthcare Foundation targets GSK over voluntary licensing of its AIDS drug patents in South Africa

AIDS Healthcare Foundation targets GSK over voluntary licensing of its AIDS drug patents in South Africa

13 Jul 2004
GSK and Boehringer Ingelheim to develop treatment for HIV infection specifically for the developing world

GSK and Boehringer Ingelheim to develop treatment for HIV infection specifically for the developing world

12 Jul 2004
Widespread prenatal HIV screening and use of antiretroviral drugs in pregnant HIV-infected women is needed

Widespread prenatal HIV screening and use of antiretroviral drugs in pregnant HIV-infected women is needed

11 Jul 2004
Nevirapine effective in reducing the risk of transmission of HIV at birth

Nevirapine effective in reducing the risk of transmission of HIV at birth

11 Jul 2004
Cheap AIDS drugs may help prevent HIV in babies in Thailand

Cheap AIDS drugs may help prevent HIV in babies in Thailand

10 Jul 2004
WHO removes two antiretroviral products from the WHO List of prequalified products

WHO removes two antiretroviral products from the WHO List of prequalified products

20 Jun 2004

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback